Skip to content

Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, sold KYMR on Jun 30, 2026

Data as of Oct 16

▼ SELL$923K7,971 shares at $115.82Bruce N. Jacobs Chief Financial OfficerKYMR Kymera Therapeutics, Inc.
Watch KYMR
Traded
Jun 30, 2026
Disclosed
Jul 2, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, sold KYMR on Jun 30, 2026TRADEDDISCLOSED
KYMRSimilar stocks (XLV — its sector index fund), rebased to KYMR's price on the disclosure day
KYMR since disclosure
−7.7%
after the sale
Similar stocks (XLV) since disclosure
+7.9%
XLV — its sector index fund

Change in closing price from Jul 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLBruce N. Jacobs Chief Financial OfficerKYMR Kymera Therapeutics, Inc.$377Kdisclosed Jul 2 · filed 2 days after the trade
  2. ▼ SELLBruce N. Jacobs Chief Financial OfficerKYMR Kymera Therapeutics, Inc.$124Kdisclosed Jul 2 · filed 2 days after the trade
  3. ▼ SELLBruce N. Jacobs Chief Financial OfficerKYMR Kymera Therapeutics, Inc.$469Kdisclosed Jul 2 · filed 2 days after the trade
  4. ▼ SELLBruce N. Jacobs Chief Financial OfficerKYMR Kymera Therapeutics, Inc.$166Kdisclosed Jul 2 · filed 2 days after the trade
  5. ▼ SELLBruce N. Jacobs Chief Financial OfficerKYMR Kymera Therapeutics, Inc.$720Kdisclosed Jul 2 · filed 2 days after the trade
  6. ▼ SELLBruce N. Jacobs Chief Financial OfficerKYMR Kymera Therapeutics, Inc.$190Kdisclosed Jul 2 · filed 2 days after the trade
  7. ▼ SELLBruce N. Jacobs Chief Financial OfficerKYMR Kymera Therapeutics, Inc.$5.9Mdisclosed Jul 2 · filed 2 days after the trade

See every trade on KYMR →